Titan Medical Inc. (TMDI) – Globe Newswire
-
Titan Announces Q&A Session with Shareholders
-
Titan Medical to Report Year-End 2023 Financial Results on March 29, 2024
-
Titan Medical Announces Change in Auditor
-
Titan Medical Reports Operating and Financial Results for the Fourth Quarter and Year End 2022 and Announces Availability of Materials for the 2023 Annual Meeting of Shareholders
-
Titan Medical Provides Bi-Weekly MCTO Status Update
-
Titan Medical Provides Bi-Weekly MCTO Status Update
-
Titan Medical Announces Receipt of MCTO
-
Titan Medical Provides Corporate Update
-
Titan Medical Announces Delays in its Annual Filings and Planned Deregistration with the SEC
-
Titan Medical Announces Decision of Nasdaq Hearings Panel to Delist Common Shares
-
Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements
-
Titan Medical Provides Corporate Update
-
Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week
-
Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
-
Titan Medical Granted Patent Covering User Experience, Further Enhancing its Intellectual Property in Robotic Assisted Surgery
-
Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process
-
Titan Medical Implements Cost-Cutting Measures to Support Strategic Review Process
-
Titan Medical Announces Commencement of Strategic Review Process
-
Titan Medical Announces American Association of Gynecologic Laparoscopy Global Congress Participation
-
Titan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder Meeting
-
Titan Medical to Issue Third Quarter 2022 Financial Results on November 10, 2022
-
Titan Medical Announces Appointment of Eric Heinz as Vice President, Market and Corporate Development
-
Titan Medical Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted Surgery
-
Titan Medical Signs Definitive Agreement with Medtronic
-
Titan Medical to Present at the H.C. Wainwright Global Investment Conference
-
Titan Medical Reports Financial Results for the Second Quarter 2022
-
Titan Medical to Issue Second Quarter 2022 Financial Results on August 11, 2022
-
Titan Medical Announces Appointment of Cary G. Vance as President and Chief Executive Officer
-
Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
-
Titan Medical Provides Update to Enos Project Timeline
-
Titan Medical to Participate at the Society of Robotic Surgery Annual Meeting
-
Titan Medical Announces Agreement with Nissha Medical Technologies
-
Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders
-
Titan Medical Appoints Bill Fahey as Vice President, Manufacturing and Operations
-
Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement
-
Microbix Announces Addition to Board of Directors
Back to TMDI Stock Lookup